Showing 1 - 7 results of 7 for search 'Yoann Cazaubon', query time: 0.03s Refine Results
  1. 1
    Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months?

    Population Pharmacokinetics Modelling and Simulation of Mitotane in Patients with Adrenocortical Carcinoma: An Individualized Dose Regimen to Target All Patients at Three Months? by Yoann Cazaubon, Yohann Talineau, Catherine Feliu, Céline Konecki, Jennifer Russello, Olivier Mathieu, Zoubir Djerada

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring

    Quantification of 15 Antibiotics Widely Used in the Critical Care Unit with a LC-MS/MS System: An Easy Method to Perform a Daily Therapeutic Drug Monitoring by Catherine Feliu, Celine Konecki, Tristan Candau, Damien Vautier, Cyril Haudecoeur, Claire Gozalo, Yoann Cazaubon, Zoubir Djerada

    Published 2021-11-01
    Get full text
    Article
  3. 3
    Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab

    Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab by Florian Rissel, Yoann Cazaubon, Syrine Saffar, Romain Altwegg, Mélanie Artasone, Claire Lozano, Thierry Vincent, Alexandre Jentzer

    Published 2023-06-01
    Get full text
    Article
  4. 4
    Development and Validation of a Non-Targeted Screening Method for Most Psychoactive, Analgesic, Anaesthetic, Anti-Diabetic, Anti-Coagulant and Anti-Hypertensive Drugs in Human Whole Blood and Plasma Using High-Resolution Mass Spectrometry

    Development and Validation of a Non-Targeted Screening Method for Most Psychoactive, Analgesic, Anaesthetic, Anti-Diabetic, Anti-Coagulant and Anti-Hypertensive Drugs in Human Whol... by Catherine Feliu, Celine Konecki, Yoann Cazaubon, Laurent Binet, Damien Vautier, Aurélie Fouley, Claire Gozalo, Zoubir Djerada

    Published 2023-01-01
    Get full text
    Article
  5. 5
    External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab

    External Evaluation of Population Pharmacokinetic Models and Bayes-Based Dosing of Infliximab by Celine Konecki, Catherine Feliu, Yoann Cazaubon, Delphine Giusti, Marcelle Tonye-Libyh, Hedia Brixi, Guillaume Cadiot, Amélie Biron, Zoubir Djerada

    Published 2021-08-01
    Get full text
    Article
  6. 6
    Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses

    Population Pharmacokinetics of Isavuconazole in Critical Care Patients with COVID-19-Associated Pulmonary Aspergillosis and Monte Carlo Simulations of High Off-Label Doses by Lucas Perez, Philippe Corne, Grégoire Pasquier, Céline Konecki, Meriem Sadek, Clément Le Bihan, Kada Klouche, Olivier Mathieu, Jacques Reynes, Yoann Cazaubon

    Published 2023-02-01
    Get full text
    Article
  7. 7
    Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life?

    Real Life Population Pharmacokinetics Modelling of Eight Factors VIII in Patients with Severe Haemophilia A: Is It Always Relevant to Switch to an Extended Half-Life? by Quentin Allard, Zoubir Djerada, Claire Pouplard, Yohann Repessé, Dominique Desprez, Hubert Galinat, Birgit Frotscher, Claire Berger, Annie Harroche, Anne Ryman, Claire Flaujac, Pierre Chamouni, Benoît Guillet, Fabienne Volot, Jean Szymezak, Philippe Nguyen, Yoann Cazaubon

    Published 2020-04-01
    Get full text
    Article

Search Tools: